Skip to main content
MIRA
NASDAQ Life Sciences

MIRA Pharmaceuticals Reports Differentiated Preclinical Data for Mira-55, Advancing Chronic Pain Program

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.94
Mkt Cap
$38.257M
52W Low
$0.9
52W High
$2.45
52W Position info
4.4% above low
Off High info
62% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MIRA is trading near its 52-week low of $0.9 (4.4% above the low).

Summary

MIRA Pharmaceuticals announced new preclinical data for its drug candidate Mira-55, showing a differentiated mechanism of action from THC and anxiolytic activity, supporting its development for chronic inflammatory pain. This positive update is significant for the clinical-stage company, which has a going concern warning.


Key Events · Product Development and Regulatory · MIRA

  • New Preclinical Data for Mira-55

    MIRA Pharmaceuticals reported new preclinical data for Mira-55, its cannabinoid analog in development for chronic inflammatory pain.

  • Differentiated Mechanism of Action

    Data showed Mira-55 did not produce central nervous system effects associated with THC and acted through a distinct pharmacological mechanism, unlike classical CB1 agonism.

  • Anxiolytic Activity Demonstrated

    Mira-55 demonstrated anxiety-reducing activity, a distinguishing feature compared to THC, which does not produce this effect.

  • Supports IND Submission

    The company believes these findings support Mira-55's continued advancement toward an Investigational New Drug (IND) submission for chronic inflammatory pain.


Analysis · MIRA · Life Sciences

This filing provides new, positive preclinical data for Mira-55, a key drug candidate for chronic inflammatory pain. The data demonstrates a differentiated mechanism of action compared to THC, notably lacking its psychoactive and central nervous system side effects, while also showing anxiety-reducing activity. For MIRA Pharmaceuticals, a company currently operating under a going concern warning and trading near 52-week lows, these findings are crucial. They strengthen the scientific basis for Mira-55, support its continued advancement towards an IND submission, and provide a much-needed positive development for its pipeline, which is essential for future financing and long-term viability.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 35.1% of the 2636 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MIRA was trading at $0.94 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $38.3M. The 52-week trading range was $0.90 to $2.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MIRA - Latest Insights

MIRA
Oct 28, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5561
Real-time Price: $0.561 info
Change: +$0.0049 (+0.88%) info
Market Cap: $22.7M info
MIRA
Oct 22, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.681
Real-time Price: $0.561 info
Change: -$0.120 (-18%) info
Market Cap: $22.7M info
MIRA
Sep 17, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.561 info
Change: -$0.1491 (-21%) info
Market Cap: $22.7M info
MIRA
Sep 17, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.561 info
Change: -$0.1491 (-21%) info
Market Cap: $22.7M info
MIRA
Aug 12, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7387
Real-time Price: $0.561 info
Change: -$0.1777 (-24%) info
Market Cap: $22.7M info